Join
Live feed
·
PRReleasevia Quantisnow
DexCom Inc. logo

Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin

ByQuantisnow·Wall Street's wire, on your screen.
DXCM· DexCom Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DXCM (DexCom Inc.) and more on Quantisnow.